Addex Therapeutics Ltd ADDXF OTC

Other OTC • Healthcare • Biotechnology • CH • USD

SharesGrow Score

44/100

1/5 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Addex Therapeutics Ltd (ADDXF) .

Criteria proven by this page:

VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.

Overall SharesGrow Score: 41/100 with 1/7 criteria passed.

SharesGrow 7-Criteria Score

44/100

SG Score

View full scorecard →

—

VALUE

N/A

No coverage

—

FUTURE

N/A

No coverage

✗

PAST

0/100

→ Income

✓

HEALTH

100/100

Debt-to-Equity & liquidity

→ Health

MOAT

50/100

→ Income

GROWTH

58/100

→ Income

✗

INCOME

10/100

→ Income

Valuation Snapshot — ADDXF

Valuation Multiples

P/E (TTM)0.0

Forward P/EN/A

PEG RatioN/A

Forward PEGN/A

P/B Ratio0.00

P/S Ratio11.43

EV/EBITDA0.0

Per Share Data

EPS (TTM)$-0.15

Book Value / Share$0.00

Revenue / Share$0.09

FCF / Share$0.00

Yields & Fair Value

Earnings YieldN/A

Dividend Yield0.00%

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year	EPS (Diluted)	Revenue	Net Income	Net Margin
2013	$-0.81	$4.43M	$-43.88M	-989.7%
2014	$-0.55	$5.24M	$-36.5M	-696%
2015	$-0.59	$7.04M	$-47.41M	-673.8%
2016	$0.34	$5.92M	$33.57M	566.8%
2017	$-0.17	$3.46M	$-19.98M	-577.7%
2018	$-0.36	$4.99M	$-45.99M	-922%
2019	$-0.08	$3.52M	$-11.71M	-333.1%
2020	$-0.14	$1.83M	$-20.65M	-1130.8%
2021	$-0.26	$4.34M	$-43.02M	-991%
2022	$-0.15	$14.7M	$-26.27M	-178.7%